Literature DB >> 25581616

Oral Delivery of Bovine Lactoferrin Using Pectin- and Chitosan-Modified Liposomes and Solid Lipid Particles: Improvement of Stability of Lactoferrin.

Xudong Yao1, Craig Bunt2, Jillian Cornish3, Siew-Young Quek4, Jingyuan Wen1.   

Abstract

A critical problem associated with delivery of bovine lactoferrin (bLf) by the oral route is low bioavailability, which is derived from the enzymatic degradation in the gastrointestinal tract and poor permeation across the intestinal epitheliums. Particulate carrier systems have been identified to protect bLf against proteolysis via encapsulation. This study aimed to evaluate the physico-chemical stability of bLf-loaded liposomes and solid lipid particles (SLPs) modified by pectin and chitosan when exposed to various stress conditions. Transmission electron microscopy results showed liposomes and SLPs had a classic shell-core structure with polymer layers surrounded on surface, but the structure appeared to be partially broken after digestion in simulated intestinal fluid (SIF). Although HPLC and sodium dodecyl sulphate-polyacrylamide gel electrophoresis methods qualitatively and quantitatively described either liposomes or SLPs could retain intact bLf against proteolysis in SIF to some extent, all liposome formulations showed rapid rate of lipolysis mediated by pancreatic enzymes. On the other hand, all SLP formulations showed higher heat resistance and greater electrolyte tolerance compared to liposome formulations. After 180 days storage time, liposome-loaded bLf was completely degraded, whereas almost 30% of intact bLf still remained in SLP formulations. Overall, SLPs are considered as primary choice for oral bLf delivery.
© 2015 John Wiley & Sons A/S.

Entities:  

Keywords:  Drug Delivery/ADMET; Nanotechnology (Drug Discovery); Protein Structure

Mesh:

Substances:

Year:  2015        PMID: 25581616     DOI: 10.1111/cbdd.12509

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  6 in total

1.  Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection.

Authors:  C H Chilton; G S Crowther; K Śpiewak; M Brindell; G Singh; M H Wilcox; T M Monaghan
Journal:  J Antimicrob Chemother       Date:  2016-01-11       Impact factor: 5.790

2.  Formulation for Oral Delivery of Lactoferrin Based on Bovine Serum Albumin and Tannic Acid Multilayer Microcapsules.

Authors:  Ece Kilic; Marina V Novoselova; Su Hui Lim; Nikolay A Pyataev; Sergey I Pinyaev; Oleg A Kulikov; Olga A Sindeeva; Oksana A Mayorova; Regan Murney; Maria N Antipina; Brendan Haigh; Gleb B Sukhorukov; Maxim V Kiryukhin
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

3.  Local application of lactoferrin promotes bone regeneration in a rat critical-sized calvarial defect model as demonstrated by micro-CT and histological analysis.

Authors:  Ryan Gao; Maureen Watson; Karen E Callon; Donna Tuari; Michael Dray; Dorit Naot; Satya Amirapu; Jacob T Munro; Jillian Cornish; David S Musson
Journal:  J Tissue Eng Regen Med       Date:  2017-04-09       Impact factor: 3.963

4.  Optimization of Conditions for Cyanidin-3-OGlucoside (C3G) Nanoliposome Production by Response Surface Methodology and Cellular Uptake Studies in Caco-2 Cells.

Authors:  Tisong Liang; Rongfa Guan; Haitao Shen; Qile Xia; Mingqi Liu
Journal:  Molecules       Date:  2017-03-13       Impact factor: 4.411

Review 5.  Development of Encapsulation Strategies and Composite Edible Films to Maintain Lactoferrin Bioactivity: A Review.

Authors:  Inés Abad; Celia Conesa; Lourdes Sánchez
Journal:  Materials (Basel)       Date:  2021-11-30       Impact factor: 3.623

6.  Impact of lactoferrin on bone regenerative processes and its possible implementation in oral surgery - a systematic review of novel studies with metanalysis and metaregression.

Authors:  Grzegorz Trybek; Maciej Jedliński; Aleksandra Jaroń; Olga Preuss; Marta Mazur; Anna Grzywacz
Journal:  BMC Oral Health       Date:  2020-08-26       Impact factor: 2.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.